Publicacions en què col·labora amb Bernat Soria Escoms (72)

2023

  1. Cell Therapy of Vascular and Neuropathic Complications of Diabetes: Can We Avoid Limb Amputation?

    International Journal of Molecular Sciences, Vol. 24, Núm. 24

  2. Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention

    BMJ

  3. Rationale for combined therapies in severe-to-critical COVID-19 patients

    Frontiers in Immunology, Vol. 14

  4. Umbilical cord mesenchymal stromal cells transplantation delays the onset of hyperglycemia in the RIP-B7.1 mouse model of experimental autoimmune diabetes through multiple immunosuppressive and anti-inflammatory responses

    Frontiers in Cell and Developmental Biology, Vol. 11

2022

  1. Considerations for Clinical Use of Mesenchymal Stromal Cells

    Handbook of Stem Cell Therapy: Volume 1 (Springer Nature), pp. 51-102

  2. Health and economic burden due to malaria in Peru over 30 years (1990–2019): Findings from the global burden of diseases study 2019

    The Lancet Regional Health - Americas, Vol. 15

  3. Pdx1 Is Transcriptionally Regulated by EGR-1 during Nitric Oxide-Induced Endoderm Differentiation of Mouse Embryonic Stem Cells

    International Journal of Molecular Sciences, Vol. 23, Núm. 7

2021

  1. Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)

    Trials, Vol. 22, Núm. 1

  2. Stemness of human pluripotent cells: Hypoxia-like response induced by low nitric oxide

    Antioxidants, Vol. 10, Núm. 9

2020

  1. AICAR stimulates the pluripotency transcriptional complex in embryonic stem cells mediated by PI3K, GSK3β, and β-Catenin

    ACS Omega, Vol. 5, Núm. 32, pp. 20270-20282

  2. Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)

    Frontiers in Immunology

  3. Mesenchymal Stromal Cell-Based Therapies as Promising Treatments for Muscle Regeneration After Snakebite Envenoming

    Frontiers in Immunology, Vol. 11

2019

  1. Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus

    Frontiers in Immunology, Vol. 10, Núm. JUN

  2. Dissecting the brain/islet axis in metabesity

    Genes, Vol. 10, Núm. 5

  3. Extra virgin olive oil diet intervention improves insulin resistance and islet performance in diet-induced diabetes in mice

    Scientific Reports, Vol. 9, Núm. 1

  4. Human mesenchymal stem cells prevent neurological complications of radiotherapy

    Frontiers in Cellular Neuroscience, Vol. 13

  5. Inadequate control of thyroid hormones sensitizes to hepatocarcinogenesis and unhealthy aging

    Aging, Vol. 11, Núm. 18, pp. 7746-7779

  6. Oestrogen receptor β mediates the actions of bisphenol-A on ion channel expression in mouse pancreatic beta cells

    Diabetologia, Vol. 62, Núm. 9, pp. 1667-1680

2018

  1. GATA6 controls insulin biosynthesis and secretion in adult β-cells

    Diabetes, Vol. 67, Núm. 3, pp. 448-460

  2. PDGF Restores the Defective Phenotype of Adipose-Derived Mesenchymal Stromal Cells from Diabetic Patients

    Molecular Therapy, Vol. 26, Núm. 11, pp. 2696-2709